Cambridge Investment Research Advisors
CLMT icon

Cambridge Investment Research Advisors’s Calumet Specialty Products CLMT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,145
Closed -$200K – 3184
2021
Q4 		$200K Buy
+15,145
New +$191K ﹤0.01% 2896
2013
Q4 		– Sell
-7,373
Closed -$201K – 1243
2013
Q3 		$201K Buy
+7,373
New +$232K 0.01% 1045

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cambridge Investment Research Advisors's CLMT Position: Q1 2022 in Review

Cambridge Investment Research Advisors sold out of Calumet Specialty Products (CLMT) in Q1 2022, closing a stake of 15,145 shares — an estimated $200K sold.

Cambridge Investment Research Advisors first reported a position in CLMT in Q3 2013 and held it in 2 quarters. The position peaked at $201K in Q3 2013. 61 funds tracked by Wall St. Rank hold CLMT as of Q1 2022.

  • Cambridge Investment Research Advisors reported no remaining Calumet Specialty Products position as of Q1 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 15,145 Calumet Specialty Products shares in Q1 2022, an estimated $200K.
  • Cambridge Investment Research Advisors first reported a position in Calumet Specialty Products in Q3 2013 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Calumet Specialty Products position peaked at $201K in Q3 2013.
  • 61 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2022, filed 12 May 2022.